Seelos Therapeutics Inc (NASDAQ:SEEL)
| 0.94 Delayed Data As of Jun 02 |  -0.0211 / -2.20%Today’s Change | 0.58 Today|||52-Week Range 1.52 | +38.44% Year-to-Date |
Latest SEEL News | Press Releases
No recent news for Seelos Therapeutics Inc.
Today’s Trading
| Previous close | 0.96 |
| Today’s open | 0.97 |
| Day’s range | 0.92 - 0.97 |
| Volume | 1,838 |
| Average volume (3 months) | 499,765 |
| Market cap | $114.5M |
Data as of 3:59pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | +4.84% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
Data as of 3:59pm ET, 06/02/2023
Financials
| Next reporting date | August 4, 2023 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$73.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
